Artificial Intelligence Clinical Genomics Interpretation Global Market Report 2025
상품코드:1855798
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
인공지능 임상 유전체학 해석 시장 규모는 최근 급격하게 확대하고 있습니다. 2024년 13억 5,000만 달러에서 2025년에는 17억 4,000만 달러로 CAGR 28.5%로 확대합니다. 지난 기간 중의 성장은 헬스케어 분야에서의 인공지능 도입 증가, 맞춤형 의료에 대한 수요 증가, 유전체 데이터 가용성 확대, AI 알고리즘을 위한 컴퓨팅 파워 강화, AI 기반 진단에 대한 투자 확대에 기인합니다.
인공지능을 통한 임상 유전체 해석 시장 규모는 향후 수년간 비약적인 성장이 예상됩니다. 2029년에는 CAGR 28.1%로 46억 8,000만 달러로 성장할 것입니다. 예측 기간의 성장은 AI 기반 유전체 툴의 광범위한 채택, 정밀의료에 대한 수요 증가, 클라우드 기반 분석의 통합 증가, 유전체 연구에 대한 정부 자금 지원 증가, 임상 의사결정에 실제 데이터 활용 확대 등에 기인한 것으로 보입니다. 예측 기간의 주요 동향으로는 AI 기반 예측 분석의 발전, 멀티오믹스 데이터 통합의 혁신, AI와 전자의무기록의 통합, 실시간 유전체 해석의 발전, 임상유전체학을 위한 설명 가능한 AI의 개발 등이 있습니다.
인공지능(AI)에 의한 임상유전체학 해석은 임상 목적으로 유전체 데이터를 분석 및 해석하기 위해 AI 주도 알고리즘이나 계산 모델을 적용하는 것을 말합니다. 이를 통해 유전자 돌연변이 확인, 질병 위험 예측, 맞춤 치료 결정을 위한 가이드를 쉽게 얻을 수 있습니다.
AI 임상 유전체 해석의 주요 구성 요소는 소프트웨어 및 서비스입니다. 소프트웨어에는 복잡한 임상 유전체 데이터의 자동 분석, 해석, 보고를 위해 설계된 AI 기반 플랫폼과 용도이 포함됩니다. 이러한 솔루션은 클라우드 기반 또는 On-Premise 환경에서 구현할 수 있습니다. 용도는 종양학, 희귀질환, 약물유전체학, 감염질환 등 다양한 분야에 걸쳐 있으며, 주요 최종사용자는 병원 및 클리닉, 연구기관, 진단연구소, 임상유전체 관련 기관을 포함합니다.
2025년 봄, 미국의 갑작스러운 관세 인상과 그에 따른 무역 마찰은 헬스케어 분야, 특히 중요한 의료기기, 진단 기기, 의약품 공급에 심각한 영향을 미치고 있습니다. 병원과 의료 서비스 프로바이더들은 수입 수술기구, 영상 진단 장비, 주사기, 카테터 등 소모품의 비용 상승에 직면해 있습니다. 이러한 비용 상승은 의료 예산을 압박하고 있으며, 일부 의료기관은 장비 업그레이드를 늦추거나 환자에게 비용을 전가하고 있습니다. 또한 원자재 및 부품에 대한 관세는 필수적인 의약품 및 의료기기의 생산을 방해하여 공급망 병목현상을 유발하고 있습니다. 이에 대해 업계는 조달 전략을 다양화하고, 가능한 한 현지 생산을 촉진하고, 생명을 구하는 의료 제품에 대한 관세 면제를 옹호하고 있습니다.
인공지능에 의한 임상 유전체 해석 산업 세계 시장 규모, 지역별 점유율, 인공지능에 의한 임상 유전체 해석 시장 점유율을 보유한 경쟁사, 상세한 인공지능에 의한 임상 유전체 해석 시장 부문, 시장 동향, 비즈니스 기회 등 인공지능에 의한 임상 유전체 해석 시장 통계를 제공합니다. 하는 The Business Research Company의 신간 보고서 시리즈 중 하나입니다. 이 인공지능을 통한 임상 유전체 해석 시장 조사 보고서는 업계의 현재와 미래 시나리오에 대한 상세한 분석을 통해 필요한 모든 것을 완벽하게 전망할 수 있도록 합니다.
맞춤형 의료에 대한 수요 증가는 인공지능을 통한 임상 유전체 해석 시장의 확대를 견인할 것으로 예측됩니다. 맞춤형 의료는 개인의 유전적, 환경적, 생활습관적 특성에 따라 진단, 치료, 예방 전략을 맞춤화하는 헬스케어 접근법입니다. 이 접근법은 특정 유전자 프로파일에 맞추어 치료법을 맞춤화함으로써 보다 효과적인 치료를 제공하고, 치료 결과를 개선하고 부작용을 줄일 수 있으므로 많은 지지를 받고 있습니다. 인공지능을 통한 임상 유전체 해석은 복잡한 유전체 데이터를 빠르게 처리하고, 정확하고 환자 맞춤형 치료법을 찾아내어 치료 효과를 높이고 의료적 의사결정의 시행착오를 최소화하는 데 기여하고 있습니다. 예를 들어 2024년 2월 미국 비영리단체인 맞춤형 의료연합(Personalized Medicine Coalition)은 미국 식품의약국(FDA)이 2023년 희귀질환 환자를 위한 16개의 새로운 개인맞춤형 치료제를 승인했으며, 이는 2022년 6개에서 증가했다고 보고했습니다. 이러한 추세는 인공지능을 통한 임상 유전체 해석 시장의 성장을 지원하고 있습니다.
인공지능을 통한 임상 유전체 해석 시장의 주요 기업은 대규모 유전체 연구를 지원하는 확장 가능한 혁신에 투자하고 있으며, 이를 통해 높은 처리량의 데이터 처리, 정확도 향상, 바이오마커 및 치료 표적의 신속한 식별을 가능하게 하고 있습니다. 확장성은 방대하고 복잡한 유전체 데이터세트를 속도와 정확도를 떨어뜨리지 않고 효율적으로 분석할 수 있는 AI 시스템의 능력을 의미하며, 데이터 양이 증가함에 따라 그 중요성이 더욱 커지고 있습니다. 예를 들어 독일에 본사를 둔 생명과학 기업 QIAGEN은 2024년 12월 복잡한 생물학적 데이터 분석을 자동화하기 위해 AI를 탑재한 Inenuity Pathway Analysis 플랫폼의 업데이트를 발표했습니다. 이번 업데이트는 인공지능을 사용하여 질병 과정에 관여하는 관련 유전자, 경로, 분자 네트워크를 식별하고, 수억 개의 AI 유래 관계를 포함하는 QIAGEN의 Biomedical Knowledge Base를 통합하여 정확하고 데이터베이스의 인사이트를 지원합니다.
2025년 5월, 미국에 본사를 둔 유전체 진단 검사 및 정밀의료 서비스를 제공하는 GeneDx는 Fabric Genomics를 비공개 금액으로 인수했습니다. 이번 인수는 GeneDx의 인공지능을 통한 임상 유전체 해석 능력, 특히 희귀질환 진단 및 신생아 유전자 스크리닝 등의 분야를 강화하기 위한 것입니다. Fabric Genomics 역시 미국에 본사를 두고 있으며, AI를 활용한 유전체 데이터 분석 소프트웨어와 의료 제공자 및 검사기관에서 사용되는 임상 판단 지원 툴을 개발하는 기업입니다.
인공지능을 통한 임상유전체 해석 시장에는 변이체 해석 서비스, 약물유전체학 해석 서비스, 종양유전체 프로파일링 서비스 등의 서비스를 제공하는 사업체가 얻는 매출이 포함됩니다. 시장 가치에는 서비스 프로바이더가 판매하거나 서비스 제공에 포함된 관련 상품의 가치도 포함됩니다. 사업체 간 거래되거나 최종 소비자에게 판매되는 재화 및 서비스만 포함됩니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세 및 Covid와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 인공지능 임상 유전체학 해석 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 용도 산업의 분석
세계의 인공지능 임상 유전체학 해석 시장 : 성장률 분석
세계의 인공지능 임상 유전체학 해석 시장 실적 : 규모와 성장, 2019-2024
세계의 인공지능 임상 유전체학 해석 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 인공지능 임상 유전체학 해석 : TAM(Total Addressable Market)
제6장 시장 세분화
세계의 인공지능 임상 유전체학 해석 시장 : 컴포넌트별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
소프트웨어
서비스
세계의 인공지능 임상 유전체학 해석 시장 : 배포 모드별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
클라우드 기반
온프레미스
세계의 인공지능 임상 유전체학 해석 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
종양학
희귀질환
약물유전체학
감염증
기타 용도
세계의 인공지능 임상 유전체학 해석 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원과 클리닉
연구기관
진단 연구소
기타 최종사용자
세계의 인공지능 임상 유전체학 해석 시장 : 서브 세분화 소프트웨어, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
게놈 데이터 해석
배리언트 해석
임상 의사결정 지원
예측 모델링
리포팅과 시각화
세계의 인공지능 임상 유전체학 해석 시장 : 서브 세분화 서비스, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
실장과 통합
컨설팅과 어드바이저리
트레이닝과 지원
데이터 관리
정비와 업그레이드
제7장 지역별·국가별 분석
세계의 인공지능 임상 유전체학 해석 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 인공지능 임상 유전체학 해석 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
인공지능 임상 유전체학 해석 시장 : 경쟁 구도
인공지능 임상 유전체학 해석 시장 : 기업 개요
F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
NVIDIA Corporation Overview, Products and Services, Strategy and Financial Analysis
Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
QIAGEN N.V. Overview, Products and Services, Strategy and Financial Analysis
Tempus Labs Inc. Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 대기업과 혁신적 기업
GeneDx Inc.
Freenome Inc.
NantHealth Inc.
SOPHiA GENETICS SA
Genomenon Inc.
DNAnexus Inc.
Lifebit Biotech Ltd.
Deep Genomics Inc.
SpeeDx Pty Ltd
PierianDx Inc.
Genuity Science Inc.
Karius Inc.
FDNA Inc.
SeqOne Genomics Inc.
Nostos Genomics Inc.
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 합병과 인수
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
인공지능 임상 유전체학 해석 시장 2029 : 새로운 기회를 제공하는 국가
인공지능 임상 유전체학 해석 시장 2029 : 새로운 기회를 제공하는 부문
인공지능 임상 유전체학 해석 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁사 전략
제36장 부록
KSA
영문 목차
영문목차
Artificial intelligence (AI) clinical genomics interpretation refers to the application of AI-driven algorithms and computational models to analyze and interpret genomic data for clinical purposes. It facilitates the identification of genetic variants, prediction of disease risk, and guidance for personalized treatment decisions.
The primary components of AI clinical genomics interpretation are software and services. The software includes AI-powered platforms and applications designed for automated analysis, interpretation, and reporting of complex clinical genomic data. These solutions can be implemented in cloud-based or on-premises environments. Applications cover areas such as oncology, rare diseases, pharmacogenomics, infectious diseases, and more, while key end-users include hospitals and clinics, research institutions, diagnostic laboratories, and other organizations engaged in clinical genomics.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.
The artificial intelligence clinical genomics interpretation market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence clinical genomics interpretation market statistics, including the artificial intelligence clinical genomics interpretation industry global market size, regional shares, competitors with the artificial intelligence clinical genomics interpretation market share, detailed artificial intelligence clinical genomics interpretation market segments, market trends, and opportunities, and any further data you may need to thrive in the artificial intelligence clinical genomics interpretation industry. This artificial intelligence clinical genomics interpretation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The artificial intelligence clinical genomics interpretation market size has grown exponentially in recent years. It will grow from $1.35 billion in 2024 to $1.74 billion in 2025 at a compound annual growth rate (CAGR) of 28.5%. The growth in the historic period can be attributed to increasing adoption of artificial intelligence in healthcare, rising demand for personalized medicine, greater availability of genomic data, enhanced computational power for AI algorithms, and growing investment in AI-driven diagnostics.
The artificial intelligence clinical genomics interpretation market size is expected to see exponential growth in the next few years. It will grow to $4.68 billion in 2029 at a compound annual growth rate (CAGR) of 28.1%. The growth in the forecast period can be attributed to wider adoption of AI-powered genomic tools, rising demand for precision medicine, increasing integration of cloud-based analytics, growing government funding for genomics research, and expanded use of real-world data in clinical decision-making. Key trends in the forecast period include advancements in AI-driven predictive analytics, innovations in multi-omics data integration, integration of AI with electronic health records, progress in real-time genomic interpretation, and development of explainable AI for clinical genomics.
The growing demand for personalized medicine is expected to support the expansion of the artificial intelligence clinical genomics interpretation market. Personalized medicine is a healthcare approach that customizes diagnosis, treatment, and prevention strategies based on an individual's genetic, environmental, and lifestyle characteristics. This approach is gaining traction due to its ability to provide more effective treatments by aligning therapies with specific genetic profiles, resulting in improved outcomes and reduced side effects. Artificial intelligence clinical genomics interpretation contributes by quickly processing complex genomic data to identify accurate, patient-specific treatment options, enhancing therapeutic effectiveness and minimizing trial-and-error in medical decision-making. For example, in February 2024, the Personalized Medicine Coalition, a US-based nonprofit organization, reported that the US Food and Drug Administration approved 16 new personalized treatments for rare disease patients in 2023, up from six in 2022. This trend supports the growth of the artificial intelligence clinical genomics interpretation market.
Leading companies in the artificial intelligence clinical genomics interpretation market are investing in scalable innovations to support large-scale genomic studies, enabling high-throughput data processing, improved accuracy, and accelerated identification of biomarkers and therapeutic targets. Scalability refers to an AI system's ability to efficiently analyze vast and complex genomic datasets without loss of speed or accuracy, which is increasingly important as data volume grows. For example, in December 2024, QIAGEN, a life sciences company based in Germany, introduced an AI-powered update to its Ingenuity Pathway Analysis platform, aimed at automating the interpretation of complex biological data. This update uses artificial intelligence to identify relevant genes, pathways, and molecular networks involved in disease processes and integrates QIAGEN's Biomedical Knowledge Base, which contains hundreds of millions of AI-derived relationships, to support accurate, data-driven insights.
In May 2025, GeneDx, a US-based provider of genomic diagnostic testing and precision medicine services, acquired Fabric Genomics for an undisclosed sum. This acquisition is intended to enhance GeneDx's artificial intelligence clinical genomics interpretation capabilities, particularly in areas such as rare disease diagnosis and neonatal genetic screening. Fabric Genomics, also based in the US, is a developer of AI-driven genomic data interpretation software and clinical decision support tools used by healthcare providers and laboratories.
Major players in the artificial intelligence clinical genomics interpretation market are F. Hoffmann-La Roche AG, NVIDIA Corporation, Illumina Inc., QIAGEN N.V., Tempus Labs Inc., GeneDx Inc., Freenome Inc., NantHealth Inc., SOPHiA GENETICS SA, Genomenon Inc., DNAnexus Inc., Lifebit Biotech Ltd., Deep Genomics Inc., SpeeDx Pty Ltd, PierianDx Inc., Genuity Science Inc., Karius Inc., FDNA Inc., SeqOne Genomics Inc., Nostos Genomics Inc.
North America was the largest region in the artificial intelligence clinical genomics interpretation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in artificial intelligence clinical genomics interpretation report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the artificial intelligence clinical genomics interpretation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The artificial intelligence clinical genomics interpretation market includes of revenues earned by entities by providing services such as variant interpretation services, pharmacogenomics interpretation services, and tumor genomic profiling services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Artificial Intelligence Clinical Genomics Interpretation Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on artificial intelligence clinical genomics interpretation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for artificial intelligence clinical genomics interpretation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence clinical genomics interpretation market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Component: Software; Services
2) By Deployment Mode: Cloud Based; On Premises
3) By Application: Oncology; Rare Diseases; Pharmacogenomics; Infectious Diseases; Other Applications
4) By End User: Hospitals And Clinics; Research Institutes; Diagnostic Laboratories; Other End User
Subsegments:
1) By Software: Genomic Data Analysis; Variant Interpretation; Clinical Decision Support; Predictive Modeling; Reporting And Visualization
2) By Services: Implementation And Integration; Consulting And Advisory; Training And Support; Data Management; Maintenance And Upgrades
3. Artificial Intelligence Clinical Genomics Interpretation Market Trends And Strategies
4. Artificial Intelligence Clinical Genomics Interpretation Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Artificial Intelligence Clinical Genomics Interpretation Growth Analysis And Strategic Analysis Framework
5.1. Global Artificial Intelligence Clinical Genomics Interpretation PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
6.1. Global Artificial Intelligence Clinical Genomics Interpretation Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Software
Services
6.2. Global Artificial Intelligence Clinical Genomics Interpretation Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cloud Based
On Premises
6.3. Global Artificial Intelligence Clinical Genomics Interpretation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oncology
Rare Diseases
Pharmacogenomics
Infectious Diseases
Other Applications
6.4. Global Artificial Intelligence Clinical Genomics Interpretation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Clinics
Research Institutes
Diagnostic Laboratories
Other End User
6.5. Global Artificial Intelligence Clinical Genomics Interpretation Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Genomic Data Analysis
Variant Interpretation
Clinical Decision Support
Predictive Modeling
Reporting And Visualization
6.6. Global Artificial Intelligence Clinical Genomics Interpretation Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Implementation And Integration
Consulting And Advisory
Training And Support
Data Management
Maintenance And Upgrades
7. Artificial Intelligence Clinical Genomics Interpretation Market Regional And Country Analysis
7.1. Global Artificial Intelligence Clinical Genomics Interpretation Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Artificial Intelligence Clinical Genomics Interpretation Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Artificial Intelligence Clinical Genomics Interpretation Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Artificial Intelligence Clinical Genomics Interpretation Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Artificial Intelligence Clinical Genomics Interpretation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Artificial Intelligence Clinical Genomics Interpretation Market
9.1. China Artificial Intelligence Clinical Genomics Interpretation Market Overview
9.2. China Artificial Intelligence Clinical Genomics Interpretation Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Artificial Intelligence Clinical Genomics Interpretation Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Artificial Intelligence Clinical Genomics Interpretation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Artificial Intelligence Clinical Genomics Interpretation Market
10.1. India Artificial Intelligence Clinical Genomics Interpretation Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Artificial Intelligence Clinical Genomics Interpretation Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Artificial Intelligence Clinical Genomics Interpretation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Artificial Intelligence Clinical Genomics Interpretation Market
11.1. Japan Artificial Intelligence Clinical Genomics Interpretation Market Overview
11.2. Japan Artificial Intelligence Clinical Genomics Interpretation Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Artificial Intelligence Clinical Genomics Interpretation Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Artificial Intelligence Clinical Genomics Interpretation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Artificial Intelligence Clinical Genomics Interpretation Market
12.1. Australia Artificial Intelligence Clinical Genomics Interpretation Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Artificial Intelligence Clinical Genomics Interpretation Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Artificial Intelligence Clinical Genomics Interpretation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Artificial Intelligence Clinical Genomics Interpretation Market
13.1. Indonesia Artificial Intelligence Clinical Genomics Interpretation Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Artificial Intelligence Clinical Genomics Interpretation Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Artificial Intelligence Clinical Genomics Interpretation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Artificial Intelligence Clinical Genomics Interpretation Market
14.1. South Korea Artificial Intelligence Clinical Genomics Interpretation Market Overview
14.2. South Korea Artificial Intelligence Clinical Genomics Interpretation Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Artificial Intelligence Clinical Genomics Interpretation Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Artificial Intelligence Clinical Genomics Interpretation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Artificial Intelligence Clinical Genomics Interpretation Market
15.1. Western Europe Artificial Intelligence Clinical Genomics Interpretation Market Overview
15.2. Western Europe Artificial Intelligence Clinical Genomics Interpretation Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Artificial Intelligence Clinical Genomics Interpretation Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Artificial Intelligence Clinical Genomics Interpretation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Artificial Intelligence Clinical Genomics Interpretation Market
16.1. UK Artificial Intelligence Clinical Genomics Interpretation Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Artificial Intelligence Clinical Genomics Interpretation Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Artificial Intelligence Clinical Genomics Interpretation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.1. Spain Artificial Intelligence Clinical Genomics Interpretation Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Artificial Intelligence Clinical Genomics Interpretation Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Artificial Intelligence Clinical Genomics Interpretation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Artificial Intelligence Clinical Genomics Interpretation Market
21.1. Eastern Europe Artificial Intelligence Clinical Genomics Interpretation Market Overview
21.2. Eastern Europe Artificial Intelligence Clinical Genomics Interpretation Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Artificial Intelligence Clinical Genomics Interpretation Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Artificial Intelligence Clinical Genomics Interpretation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Artificial Intelligence Clinical Genomics Interpretation Market
22.1. Russia Artificial Intelligence Clinical Genomics Interpretation Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Artificial Intelligence Clinical Genomics Interpretation Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Artificial Intelligence Clinical Genomics Interpretation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Artificial Intelligence Clinical Genomics Interpretation Market
23.1. North America Artificial Intelligence Clinical Genomics Interpretation Market Overview
23.2. North America Artificial Intelligence Clinical Genomics Interpretation Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Artificial Intelligence Clinical Genomics Interpretation Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Artificial Intelligence Clinical Genomics Interpretation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Artificial Intelligence Clinical Genomics Interpretation Market
24.1. USA Artificial Intelligence Clinical Genomics Interpretation Market Overview
24.2. USA Artificial Intelligence Clinical Genomics Interpretation Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Artificial Intelligence Clinical Genomics Interpretation Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Artificial Intelligence Clinical Genomics Interpretation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.2. Canada Artificial Intelligence Clinical Genomics Interpretation Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Artificial Intelligence Clinical Genomics Interpretation Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Artificial Intelligence Clinical Genomics Interpretation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Artificial Intelligence Clinical Genomics Interpretation Market
26.1. South America Artificial Intelligence Clinical Genomics Interpretation Market Overview
26.2. South America Artificial Intelligence Clinical Genomics Interpretation Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Artificial Intelligence Clinical Genomics Interpretation Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Artificial Intelligence Clinical Genomics Interpretation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Artificial Intelligence Clinical Genomics Interpretation Market
27.1. Brazil Artificial Intelligence Clinical Genomics Interpretation Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Artificial Intelligence Clinical Genomics Interpretation Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Artificial Intelligence Clinical Genomics Interpretation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Artificial Intelligence Clinical Genomics Interpretation Market
28.1. Middle East Artificial Intelligence Clinical Genomics Interpretation Market Overview
28.2. Middle East Artificial Intelligence Clinical Genomics Interpretation Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Artificial Intelligence Clinical Genomics Interpretation Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Artificial Intelligence Clinical Genomics Interpretation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Artificial Intelligence Clinical Genomics Interpretation Market
29.1. Africa Artificial Intelligence Clinical Genomics Interpretation Market Overview
29.2. Africa Artificial Intelligence Clinical Genomics Interpretation Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Artificial Intelligence Clinical Genomics Interpretation Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Artificial Intelligence Clinical Genomics Interpretation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Artificial Intelligence Clinical Genomics Interpretation Market Competitive Landscape And Company Profiles
